Home/Filings/4/0001415889-25-001934
4//SEC Filing

Huang Michael F. 4

Accession 0001415889-25-001934

CIK 0001484565other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:25 PM ET

Size

7.9 KB

Accession

0001415889-25-001934

Insider Transaction Report

Form 4
Period: 2025-01-21
Huang Michael F.
Sr. VP of Clinical Development
Transactions
  • Award

    Employee stock option (right to buy)

    2025-01-21+13,80013,800 total
    Exercise: $49.17Exp: 2035-01-21Common Stock (13,800 underlying)
  • Award

    Common Stock

    2025-01-21+6,40041,400 total
Footnotes (3)
  • [F1]These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on each annual anniversary of December 15, 2024, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.
  • [F2]Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
  • [F3]1/48th of the shares subject to the option shall vest on February 1, 2025 and 1/48th of the remaining shares subject to the option shall vest on each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.

Issuer

SOLENO THERAPEUTICS INC

CIK 0001484565

Entity typeother

Related Parties

1
  • filerCIK 0002019992

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:25 PM ET
Size
7.9 KB